» Articles » PMID: 3105134

Overview of the Development of Orthoclone OKT3: Monoclonal Antibody for Therapeutic Use in Transplantation

Overview
Journal Transplant Proc
Specialty General Surgery
Date 1987 Apr 1
PMID 3105134
Citations 19
Authors
Affiliations
Soon will be listed here.
Citing Articles

Integrated Imaging Probe and Bispecific Antibody Development Enables In Vivo Targeting of Glypican-3-Expressing Hepatocellular Carcinoma.

Habibollahi P, Gurevich A, Hui J, Weinfurtner K, McClung G, Adler J Mol Cancer Ther. 2024; 23(12):1815-1826.

PMID: 39312187 PMC: 11726262. DOI: 10.1158/1535-7163.MCT-23-0470.


The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies.

Gogesch P, Dudek S, van Zandbergen G, Waibler Z, Anzaghe M Int J Mol Sci. 2021; 22(16).

PMID: 34445651 PMC: 8396266. DOI: 10.3390/ijms22168947.


Therapies for rare diseases: therapeutic modalities, progress and challenges ahead.

Tambuyzer E, Vandendriessche B, Austin C, Brooks P, Larsson K, Miller Needleman K Nat Rev Drug Discov. 2019; 19(2):93-111.

PMID: 31836861 DOI: 10.1038/s41573-019-0049-9.


Molecular and functional analysis of monoclonal antibodies in support of biologics development.

Wang X, An Z, Luo W, Xia N, Zhao Q Protein Cell. 2017; 9(1):74-85.

PMID: 28733914 PMC: 5777976. DOI: 10.1007/s13238-017-0447-x.


Therapeutic antibodies: their mechanisms of action and the pathological findings they induce in toxicity studies.

Suzuki M, Kato C, Kato A J Toxicol Pathol. 2015; 28(3):133-9.

PMID: 26441475 PMC: 4588207. DOI: 10.1293/tox.2015-0031.